Cargando…
XPA, XPC, and XPD Modulate Sensitivity in Gastric Cisplatin Resistance Cancer Cells
Cisplatin is an election drug widely used in clinic for the treatment of advanced gastric cancer. However, the heterogeneity of the gastric tumors and its resistance to the drugs, make in some cases the response very low and the prognosis unpredictable. In this manuscript we aim to find the molecula...
Autores principales: | Pajuelo-Lozano, Natalia, Bargiela-Iparraguirre, Jone, Dominguez, Gemma, Quiroga, Adoracion G., Perona, Rosario, Sanchez-Perez, Isabel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6199368/ https://www.ncbi.nlm.nih.gov/pubmed/30386247 http://dx.doi.org/10.3389/fphar.2018.01197 |
Ejemplares similares
-
Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine
por: Mlak, Radosław, et al.
Publicado: (2018) -
Regulatory effects of miR-19a on MAD2 expression and tumorigenesis in gastric cancer
por: Bargiela-Iparraguirre, J., et al.
Publicado: (2023) -
Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD
por: Chiang, Chun-Chi, et al.
Publicado: (2010) -
A Significant Increasing Risk Association between Cigarette Smoking and XPA and XPC Genes Polymorphisms
por: Almushawwah, Safiah, et al.
Publicado: (2023) -
Targeting MAD2 modulates stemness and tumorigenesis in human Gastric Cancer cell lines
por: Pajuelo-Lozano, Natalia, et al.
Publicado: (2020)